The Division of Hematology's major academic goal is to promote the understanding of a wide scope of hematological diseases. The diagnosis and management of these diseases require a broadly based knowledge in bone marrow physiology and biochemistry, tumor cell growth, hemostasis and thrombosis, red blood cell and hemoglobin molecular biology and immunology. The division has developed good collaboration with the departments of Pathology and Laboratory Medicine and Pharmacology in The University of Texas Medical School and The University of Texas M.D. Anderson Cancer Center. The interactions enhance research, teaching and patient activities.

The division provides both inpatient and ambulatory care services. It provides consultation services at Hermann and Lyndon B. Johnson General hospitals and M.D. Anderson Cancer Center. The Gulf States Hemophilia Diagnostic and Treatment Center is operated under the direction of this division. The Special Hemostasis laboratory performs platelet aggregation and adhesiveness studies, clotting factor and complement component assays and platelet antibody tests.

Research in the division includes an interdepartmental program in vascular diseases, prostaglandin research, monocyte-macrophage physiology and biochemistry, clinical and laboratory hyperthermia, cell differentiation and platelet and endothelial cell function.

Harinder Juneja, M.D., Professor and Division Director

Professor
Richard Kulmacz, Ph.D.
Ah-Lim Tsai, Ph.D.

Associate Professor
Nena  Matijevic, Ph.D.
Lee-Ho Wang, Ph.D.

Assistant Professor
Miguel Escobar, M.D.

Emeritus Professor
Kenneth K. Wu, M.D., Ph.D.